ArticleDegenerative neurological and neuromuscular disease2026
Disabilities and Health-Related Quality of Life in Multiple Sclerosis: Prospective 10-year Web-Based Study of a Population-Based Real-Life Cohort in the Netherlands.
Article in Degenerative neurological and neuromuscular disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To assess at population level long-term changes in disabilities and health-related quality of life (HRQoL) in persons with multiple sclerosis (PwMS) in the Netherlands. Patients and Methods: A prospective web-based study in a real-world population-based self-enrolled cohort; 6-month assessments by means of the Multiple Sclerosis Impact Profile (MSIP) and Multiple Sclerosis Quality of Life-54 (MSQoL-54) questionnaires; Generalized Linear Mixed Models (GLMM) analysis; predetermined anchor points 5, 8 and 10 years follow-up. Results: Nation-wide 391 patients started (2011-2012), 272 participants were included in the MSIP and 267 in the MSQoL-54 analyses. Female 74%, mean (standard deviation) age 45 (11) years. Baseline Expanded Disability Status Scale scores: 58.9% 0.0-4.0, 35.5% 4.5-6.5, 5.6% >6.5. Baseline demographic and disease characteristics did not differ between participants with and without follow-up data. GLMM indicated that after 10 years disability related to Activities of Daily Living and Basic Movement Activities had increased. Conversely, at 5, 8 and 10 years an improvement was reported in disability related to Lack of Support from Environmental Factors, more specifically Professional Care and Assistance, and Social Security Services. The other MSIP disabilities and symptoms remained stable over time, as did the physical and mental MSQoL-54 scores. Conclusion: Our findings indicate that in the Dutch MS population in the period 2011-2021 the limitations in activities of daily living and in basic movement activities worsened over time. The improved support from professional care, professional assistance and social security services may be related to the implementation of nation-wide decentralized legislation to support people with disabilities, and the emergence of MS-specific neurological and nursing care. These findings at population level regarding the long-term course of disabilities and HRQoL in PwMS in the Netherlands in the era of (high) efficacy disease-modifying drugs may be useful for policymakers, healthcare providers, and patient organizations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.